Jonathan Sherman, MD
Neurological Surgery · Eugene, ORNPI 1902800733
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,848 of the $18,048 with a category attached, or 71.2%. Spine Wave, Inc. accounts for 84.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $13,241 and has fallen 94.2% since, to $773 in 2025.
Across 45 payments — averaging $401.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spine Wave, Inc.$15K
- Si-bone, Inc.$2K
- Spineart USA Inc$591
- Surgalign Spine Technologies, Inc.$195
- Abbott$87
- Zimmer Biomet$86
- plus $50 from 1 others
What the payments were for
- Consulting fees$12,84871%
- Travel & lodging$1,5469%
- Food & beverage$3,65420%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spine Wave, Inc. | 27 | $15,300 |
| Si-bone, Inc. | 4 | $1,740 |
| Spineart USA Inc | 2 | $591 |
| Surgalign Spine Technologies, Inc. | 5 | $195 |
| Abbott | 4 | $87 |
| Zimmer Biomet | 1 | $86 |
| Nalu Medical, Inc. | 2 | $50 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Spinal Implants$12,804
- iFuse Implant$1,658
- SPINAL IMPLANT$636
- Bone Substitute$118
- SlMMETRY$110
How this compares
$18,048 in reported general payments places this provider in the 80th percentile of 95 neurological surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 32 | $380 |
| Meloxicam | 54 | $351 |
| Duloxetine Hcl | 14 | $232 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $144 |
| Oxycodone Hcl | 15 | $123 |
| Tramadol Hcl | 25 | $100 |
| Prednisone | 21 | $77 |
| Cyclobenzaprine Hcl | 14 | $71 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Eugene
- Glenn KeiperEugene$153K
- Carmina AngelesEugene$97K
- Catherine GalloEugene$4K
- Alp OzpinarSpringfield$235K
- Josha WoodwardPortland$145K
- Seth OliveriaPortland$97K
- David Mazur-HartHillsboro$69K
- Daniel ClearyPortland$63K
- Helen ShiPortland$61K
- Adam LipsonPortland$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.